Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
Researchers are trying to understand why people with indigestion and diabetes mellitus have
gastrointestinal symptoms and in particular to understand whether symptoms are related to
increased sensitivity to nutrients in the small intestine. As part of this investigation, a
medication called ondansetron will also be studied to determine its effects on
gastrointestinal function and associated symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)